DaVita Financial Statements (DVA)
|
|
|
|
Report date
|
|
|
11.02.2022 |
22.02.2023 |
14.02.2024 |
13.02.2025 |
11.02.2026 |
|
05.05.2026 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
11 619 |
11 610 |
12 140 |
12 816 |
13 643 |
|
13 835 |
|
Operating Income, bln rub |
|
|
1 797 |
1 339 |
1 603 |
2 090 |
2 011 |
|
2 077 |
|
EBITDA, bln rub |
? |
|
2 484 |
2 056 |
2 321 |
2 725 |
2 642 |
|
2 700 |
|
Net profit, bln rub |
? |
|
978.5 |
560.4 |
691.5 |
936.3 |
746.8 |
|
781.4 |
|
|
OCF, bln rub |
? |
|
1 931 |
1 565 |
2 059 |
2 022 |
1 887 |
|
2 027 |
|
CAPEX, bln rub |
? |
|
641.5 |
603.4 |
568.0 |
555.4 |
575.9 |
|
534.6 |
|
FCF, bln rub |
? |
|
1 289 |
961.1 |
1 491 |
1 467 |
1 311 |
|
1 493 |
|
Dividend payout, bln rub
|
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
|
OPEX, bln rub |
|
|
1 849 |
2 061 |
2 218 |
2 127 |
1 674 |
|
2 226 |
|
Cost of production, bln rub |
|
|
7 972 |
8 210 |
8 320 |
8 599 |
9 959 |
|
9 533 |
|
R&D, bln rub |
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
Interest expenses, bln rub |
|
|
285.3 |
357.0 |
398.6 |
470.5 |
549.7 |
|
559.8 |
|
|
Assets, bln rub |
|
|
17 121 |
16 928 |
16 894 |
17 285 |
17 480 |
|
17 499 |
|
Net Assets, bln rub |
? |
|
755.5 |
712.3 |
1 056 |
121.1 |
-651.1 |
|
-755.5 |
|
Debt, bln rub |
|
|
11 975 |
11 822 |
11 116 |
12 067 |
15 050 |
|
13 221 |
|
Cash, bln rub |
|
|
484.2 |
321.8 |
391.7 |
846.0 |
782.1 |
|
748.7 |
|
Net debt, bln rub |
|
|
11 491 |
11 501 |
10 725 |
11 221 |
14 268 |
|
12 472 |
|
|
Ordinary share price, rub |
|
|
113.8 |
74.7 |
104.8 |
149.6 |
113.6 |
|
198.8 |
|
Number of ordinary shares, mln |
|
|
105.2 |
93.0 |
90.8 |
85.0 |
86.1 |
|
67.4 |
|
|
Market cap, bln rub |
|
|
11 971 |
6 944 |
9 511 |
12 710 |
9 782 |
|
13 400 |
|
EV, bln rub |
? |
|
23 462 |
18 444 |
20 236 |
23 931 |
24 050 |
|
25 872 |
|
Book value, bln rub |
|
|
-6 468 |
-6 547 |
-6 260 |
-7 452 |
-8 418 |
|
-8 567 |
|
|
EPS, rub |
? |
|
9.30 |
6.03 |
7.62 |
11.0 |
8.67 |
|
11.6 |
|
FCF/share, rub |
|
|
12.3 |
10.3 |
16.4 |
17.3 |
15.2 |
|
22.2 |
|
BV/share, rub |
|
|
-61.5 |
-70.4 |
-68.9 |
-87.7 |
-97.8 |
|
-127.1 |
|
|
EBITDA margin, % |
? |
|
21.4% |
17.7% |
19.1% |
21.3% |
19.4% |
|
19.5% |
|
Net margin, % |
? |
|
8.42% |
4.83% |
5.70% |
7.31% |
5.47% |
|
5.65% |
|
FCF yield, % |
? |
|
10.8% |
13.8% |
15.7% |
11.5% |
13.4% |
|
11.1% |
|
ROE, % |
? |
|
129.5% |
78.7% |
65.5% |
773.1% |
-114.7% |
|
-103.4% |
|
ROA, % |
? |
|
5.71% |
3.31% |
4.09% |
5.42% |
4.27% |
|
4.47% |
|
|
P/E |
? |
|
12.2 |
12.4 |
13.8 |
13.6 |
13.1 |
|
17.1 |
|
P/FCF |
|
|
9.28 |
7.22 |
6.38 |
8.67 |
7.46 |
|
8.98 |
|
P/S |
? |
|
1.03 |
0.60 |
0.78 |
0.99 |
0.72 |
|
0.97 |
|
P/BV |
? |
|
-1.85 |
-1.06 |
-1.52 |
-1.71 |
-1.16 |
|
-1.56 |
|
EV/EBITDA |
? |
|
9.44 |
8.97 |
8.72 |
8.78 |
9.10 |
|
9.58 |
|
Debt/EBITDA |
|
|
4.63 |
5.59 |
4.62 |
4.12 |
5.40 |
|
4.62 |
|
|
R&D/CAPEX, % |
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
|
CAPEX/Revenue, % |
|
|
5.52% |
5.20% |
4.68% |
4.33% |
4.22% |
|
3.86% |
|
| DaVita shareholders |
